Evidence map›Paper›PMID 36526890›Full record

ArticleCommunications biology2022

The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection.

Alyssa C Fears, Edith M Walker, Nicole Chirichella, Nadia Slisarenko, Kristen M Merino, Nadia Golden, Breanna Picou, Skye Spencer, Kasi E Russell-Lodrigue, Lara A Doyle-Meyers and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. CD4Science advances · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Alyssa C FearsDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Edith M WalkerDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Nicole ChirichellaDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Nadia SlisarenkoDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Kristen M MerinoDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Nadia GoldenDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.
Breanna PicouHigh Containment Research Performance Core, Tulane National Primate Research Center, Covington, LA, USA.
Skye SpencerHigh Containment Research Performance Core, Tulane National Primate Research Center, Covington, LA, USA.
Kasi E Russell-LodrigueDivision of Veterinary Medicine, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0003-3719-0779
Lara A Doyle-MeyersDivision of Veterinary Medicine, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0003-0212-9548
Robert V BlairDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0001-9616-9414
Brandon J BeddingfieldDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0002-9438-1304
Nicholas J ManessDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0002-9332-7891
Chad J RoyDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA.ORCID 0000-0002-1710-6974
Namita RoutDivision of Microbiology, Tulane National Primate Research Center, Covington, LA, USA. nrout@tulane.edu.ORCID 0000-0003-0609-0767
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
The role of the CMV-associated reactive oxygen species in age-relatedP20GM103629 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA · 2012 to 2021
$22.4M
Genetically Modified Gamma Delta T Cells to Target SIV ReservoirsR33AI136100 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA · 2020 to 2022
$1.5M
Role of Lipid Antigen-Specific T Cells in the Anti-mycobacterial Immune Response of BCG/SIV Infected MacaquesR21AI140840 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA · 2018 to 2019
$487k
NIAID NIH HHS HHSN272201700033INIAID NIH HHS R21 AI140840NIAID NIH HHS R21AI140840NIAID NIH HHS R33 AI136100NIGMS NIH HHS P20 GM103629NIGMS NIH HHS P20GM103629NIH HHS P51 OD011104NIH HHS R33AI136100
6 · The paper itself

Abstract

Although most SARS-CoV-2 infections are mild, some patients develop systemic inflammation and progress to acute respiratory distress syndrome (ARDS). However, the cellular mechanisms underlying this spectrum of disease remain unclear. γδT cells are T lymphocyte subsets that have key roles in systemic and mucosal immune responses during infection and inflammation. Here we show that peripheral γδT cells are rapidly activated following aerosol or intra-tracheal/intra-nasal (IT/IN) SARS-CoV-2 infection in nonhuman primates. Our results demonstrate a rapid expansion of Vδ1 γδT cells at day1 that correlate significantly with lung viral loads during the first week of infection. Furthermore, increase in levels of CCR6 and Granzyme B expression in Vδ1 T cells during viral clearance imply a role in innate-like epithelial barrier-protective and cytotoxic functions. Importantly, the early activation and mobilization of circulating HLA-DR

Indexed as

COVID-19AnimalsInflammationPrimatesSARS-CoV-2T-Lymphocyte Subsets

Identifiers

PMID36526890
PMCPMC9756695
OpenAlexW4312065190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.